Fludarabine, as well as 2-chlorodeoxyadenosine, can induce eosinophilia during treatment of lymphoid malignancies

British Journal of Haematology

Volumn 94, Issue 4, 1996, Pages 709-712

  Lärfars, Gerd ^a   Udén Blohmé, Ann Mari ^a   Samuelsson, Jan ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

2 Chlorodeoxyadenosine; Chronic lymphocytic leukaemia; Eosinophilia; Fludarabine; Follicular lymphoma

Indexed keywords

CLADRIBINE; FLUDARABINE;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; EOSINOPHILIA; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029759132     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1845.x     Document Type: Article

References (10)

1. Hochster, H.S., Kim, K., Green, M.D., Mann, R.B., Neiman, R.S., Oken, M.M., Cassileth, P.H.A., Stool, P., Ritch, P. & O'Connell, M.J. (1992) Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study. Journal of Clinical Oncology, 10, 28-32.
2. Juliusson, G., Lenkei, R., Tjonnfjord, G., Heldal, D. & Liliemark, J. (1995) Neutropenic fever following cladribine therapy for symptomatic hairy-cell leukemia: predictive factors and effects of granulocyte-macrophage colony-stimulating factor. Annals of Oncology, 6, 371-375.
3. Juliusson, C. & Liliemark, J. (1993) High complete remission rate from 2-chloro-2′-deoxyadenosine (CdA) in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count. Journal of Clinical Oncology, 11, 679-689.
4. Kantarjian, H.M., Alexanian, R., Koller, C.A., Kurzrock, R. & Keating, M.J. (1990) Fludarabine treatment in macroglobulinemic lymphoma. Blood, 75, 1929-1931.
5. Keating, M.J., O'Brien, S., Kantarjian, H.M., Plunkett, W., Estey, E., Koller, C.A., Beran, M. & Freireich, E.J. (1993) Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood, 81, 2878-2884.
6. Liliemark, J., Albertoni, F., Hassan, M. & Juliusson, G. (1992) On the bioavailability of oral and subcutaneous 2-chloro-2′-deoxyadenosine (CdA) in humans: alternative routes of administration. Journal of Clinical Oncology, 10, 1514-1518.
7. Piro, L.D., Carrera, C.J., Carson, D.A. & Beutler, E. (1990) Lasting remission in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. New England Journal of Medicine, 322, 1117-1121.
8. Robak, T., Blasinska-Morawiec, N. & Krykowski, E. (1992) Transient eosinophilia in a patient with hairy cell leukaemia treated with 2-chlorodeoxyadenosine. Acta Haematologica Polonica, 23, 285-290.
9. Rutella, S., Sica, S., Rumi, C., Martucci, R., Etuk, B., De Stefano, V., Testa, U., Leone, G. & Peschle, C. (1996) Hypereosinophilia during 2-chlorodeoxyadenosine treatment for hairy cell leukaemia. British Journal Haematology, 92, 426-428.
10. Saven, A., Lemon, R.H., Kosty, M., Beutler, E. & Piro, L.D. (1995) 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukaemia. Journal of Clinical Oncology, 13, 570-574.